RBM5 inhibits tumorigenesis of gliomas through inhibition of Wnt/β-catenin signaling and induction of apoptosis

BACKGROUND: Gliomas are one of the most common malignant brain tumors and bring a big threat to human life as traditional therapy is unsatisfactory. RBM5 was a RNA-binding motif protein and was reported as a tumor suppressor. But the role of RBM5 in gliomas was unknown. METHODS: The mRNA level of RB...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yuanpei, Sheng, Hongling, Meng, Lei, Yue, Hongsheng, Li, Bo, Zhang, Aijun, Dong, Yanan, Liu, Yuguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219762/
https://www.ncbi.nlm.nih.gov/pubmed/28061901
http://dx.doi.org/10.1186/s12957-016-1084-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219762/
https://www.ncbi.nlm.nih.gov/pubmed/28061901
http://dx.doi.org/10.1186/s12957-016-1084-1

Ejemplares similares